Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract Reconstruction
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Study ID
- NCT07800819
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Adenocarcinoma of the Esophagogastric Junction
- Gastric Adenocarcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Proximal gastrectomy with double-tract reconstruction — PROCEDURECurative proximal gastrectomy followed by double-tract reconstruction performed as part of routine clinical care. The study does not assign treatment and retrospectively analyzes existing clinical data.
Study Details
This two-center retrospective observational cohort study compares Chinese and Russian patients who underwent curative proximal gastrectomy with double-tract reconstruction for proximal gastric adenocarcinoma or Siewert type II/III adenocarcinoma of the esophagogastric junction. The study evaluates postoperative reflux, nutritional status, perioperative outcomes, complications, and long-term survival. Propensity score matching will be used to improve comparability between the two cohorts.
Key Dates
- First listed
- Sep 2, 2026
- Start date
- Aug 15, 2026
- Status verified
- Aug 2026
- Primary completion
- Jun 15, 2027
- Completion
- Aug 15, 2027
Study Design
- Enrollment
- 250 participants (estimated)
Arms
- Arm: Chinese cohortPatients treated at the First Affiliated Hospital of Nanjing Medical University who underwent proximal gastrectomy with double-tract reconstruction during the study source period.
- Arm: Russian cohortPatients treated at the Moscow Clinical Scientific Center named after A.S. Loginov who underwent proximal gastrectomy with double-tract reconstruction during the study source period.
Primary Outcome Measure
Endoscopic reflux esophagitis [ Time Frame: 1 year after surgery ]
Central Contacts
- Hao Xu+86-138-5153-0117
Related Studies
- Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric CancerPHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesPHASE2 · Recruiting · Dan Zandberg · Pittsburgh, Pennsylvania
- Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric AdenocarcinomaPHASE2 · Recruiting · University of Wisconsin, Madison · Madison, Wisconsin
- Magnetic Sentinel Lymph Node Mapping in Gastric CancerPHASE1 · Not Yet Recruiting · M.D. Anderson Cancer Center · Houston, Texas